There are few things more important than health, but a recent report suggests that the public has declining trust in traditional healthcare institutions to protect theirs.
When it comes to the pharmaceutical industry, a company’s marketing or educational efforts require not just a stellar set of global plans and materials, but also the ability to adapt global
Recently, pharmaphorum spoke with Sebastian Katz, chief strategy officer of specialty healthcare company Stein Holding Group (SteinCares), to discuss the announcement of its licensing agree
Eli Lilly has added $1 billion to its investment plan for a new manufacturing facility in Ireland that will be used to produce its Alzheimer's therapy donanemab.
The Life Sciences Generative AI Council aims to bring together the best minds in pharma, academia, and technology to advance the use of GenAI in life sciences R&D, seeking through pinpo